tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Unusually active option classes on open October 30th
PremiumThe FlyUnusually active option classes on open October 30th
2d ago
Balanced Outlook on Bristol-Myers Squibb: Hold Rating Amid Strong Immuno-Oncology Growth and Pipeline Uncertainties
Premium
Ratings
Balanced Outlook on Bristol-Myers Squibb: Hold Rating Amid Strong Immuno-Oncology Growth and Pipeline Uncertainties
2d ago
Bristol-Myers Squibb Reports Q3 2025 Financial Results
Premium
Company Announcements
Bristol-Myers Squibb Reports Q3 2025 Financial Results
2d ago
BMY Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsBMY Upcoming Earnings Report: What to Expect?
4d ago
Hold Rating for Bristol-Myers Squibb Amid Fair Valuation and Mixed Growth Prospects
Premium
Ratings
Hold Rating for Bristol-Myers Squibb Amid Fair Valuation and Mixed Growth Prospects
5d ago
Bristol Myers’ Sotyktu shows efficacy in arthritis and SLE
Premium
The Fly
Bristol Myers’ Sotyktu shows efficacy in arthritis and SLE
5d ago
Bristol-Myers Squibb: Hold Rating Amid Market Challenges and Uncertain Growth Prospects
PremiumRatingsBristol-Myers Squibb: Hold Rating Amid Market Challenges and Uncertain Growth Prospects
11d ago
Bristol Myers, SystImmune report global Phase 1 results of Iza-bren
Premium
The Fly
Bristol Myers, SystImmune report global Phase 1 results of Iza-bren
15d ago
Neutral Outlook for Bristol-Myers Squibb Amidst Competitive Pressures and Growth Challenges
Premium
Ratings
Neutral Outlook for Bristol-Myers Squibb Amidst Competitive Pressures and Growth Challenges
16d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100